Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth (CMT) disease is a hereditary motor and sensory neuropathy characterized by loss of muscle and touch sensation. Discover the latest research on CMT here.

April 8, 2021

Genotype-phenotype correlations of KIF5A stalk domain variants.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Eva M J de BoerMichael A van Es
April 8, 2021
Open Access

Associations between Neurological Diseases and Mutations in the Human Glycyl-tRNA Synthetase.

Biochemistry. Biokhimii︠a︡
Ekaterina S VinogradovaEkaterina Yu Nikonova
April 5, 2021

Involuntary moaning in a Hispanic family with eight affected members.

Parkinsonism & Related Disorders
Maria GisatulinMarcelo Merello
April 5, 2021

Drosophila models to study causative genes for human rare intractable neurological diseases.

Experimental Cell Research
Masamitsu YamaguchiHideki Yoshida
April 1, 2021
Case Report
Open Access

A Patient with Noonan Syndrome with a KRAS Mutation Who Presented Severe Nerve Root Hypertrophy.

Case Reports in Neurology
Yoshihito AndoYoko Aoki
March 29, 2021

Reference values for lower limb nerve ultrasound and its diagnostic sensitivity.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Jingwen NiuMingsheng Liu
March 28, 2021

Association between restless legs syndrome and peripheral neuropathy: A systematic review and meta-analysis.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Félix Javier Jiménez-JiménezJosé A G Agúndez
March 26, 2021
Open Access

[A case of Charcot-Marie-Tooth disease type 2Z caused by MORC2 S87L mutation mimicking spinal muscular atrophy].

Rinshō shinkeigaku = Clinical neurology
Daisuke YamamotoShun Shimohama
March 23, 2021
Open Access

CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS.

Proceedings of the National Academy of Sciences of the United States of America
Litao SunXiang-Lei Yang
March 23, 2021
Open Access

Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.

Communications Biology
Suzan BoutaryLiliane Massaad-Massade
March 16, 2021
Open Access

Gait parameters as tools for analyzing phenotypic alterations of a mouse model of Charcot-Marie-Tooth disease.

Animal Cells and Systems
Sun Hee HwangYoung Bin Hong
March 14, 2021

Dynamic plantar pressure patterns in children and adolescents with Charcot-Marie-Tooth disease.

Gait & Posture
Juliana CardosoAna Claudia Mattiello-Sverzut
March 12, 2021
Open Access

AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.

Gene Therapy
Alexia KagiavaKleopas A Kleopa
March 6, 2021
Open Access

HINT1 neuropathy in Norway: clinical, genetic and functional profiling.

Orphanet Journal of Rare Diseases
Silvia Amor-BarrisKristien Peeters
March 5, 2021
Open Access

GDAP1 loss of function inhibits the mitochondrial pyruvate dehydrogenase complex by altering the actin cytoskeleton

BioRxiv : the Preprint Server for Biology
C. WolfAxel Methner
March 3, 2021

A prospective study on surgical management of foot deformities in Charcot Marie tooth disease.

Journal of the Peripheral Nervous System : JPNS
Gita RamdharryMatilde Laurá

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

4H Leukodystrophy

4H Leukodystrophy involves hypomyelination with hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3 Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. Here is the latest research on this disease.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

© 2021 Meta ULC. All rights reserved